NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
基本信息
- 批准号:10670536
- 负责人:
- 金额:$ 19.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAdverse eventAlzheimer&aposs disease related dementiaAmericanBehaviorBehavior TherapyCaringCenters for Disease Control and Prevention (U.S.)ClinicalClinical ManagementClinical ResearchCollaborationsCommunicable DiseasesComparative Effectiveness ResearchComputerized Medical RecordConsultationsDataData SetDiagnosisDiagnostic testsDisease OutbreaksFundingGoalsGuidelinesHealthcareHealthcare SystemsIncidenceInfectionInformation CentersLaboratoriesLeadershipLong-Term CareLungMedicare claimMedicare/MedicaidMonitorNursesNursing HomesPatient riskPhasePhysical FunctionPoliciesPopulation HeterogeneityPopulation SurveillancePrevalencePublic HealthRandomized Clinical TrialsRecordsReportingResearchResearch PersonnelResearch SupportResourcesTest ResultTextTimeUniversitiesVaccinationVendorVirusbaseclinical careclinically relevantcognitive functioncollaboratorycoronavirus diseaseevidence basemedication administrationmemberrecruitrepositoryresearch studysystems research
项目摘要
PROJECT SUMMARY
The NIA IMPACT Collaboratory COVID related supplement that funded the Long Term
Care Data Cooperative [U54AG063546-02S6] established a cooperative that is
compiling a centralized repository of nursing home electronic medical record (EMR)
data from three different EMR vendors. Numerous nursing home companies using one
of these three vendors have signed up as members, authorizing their EMR vendor to
transfer clinically relevant data, complete with identifiers, to a centralized repository
operating under the auspices of the American Health Care Association (AHCA) a
membership association of most US nursing homes [https://www.ahcancal.org/Data-
and-Research/Pages/LTC-Data-Cooperative.aspx]. In addition to the regulatory
required Minimum Data Set information, EMR data being consolidated include all
prevalent and incident diagnoses, orders, medication administration records, change of
condition records, daily vital signs, incident reports, vaccinations, behavior tracking,
daily changes in cognitive and physical functioning, and for some facilities, laboratory
and diagnostic test results.
To facilitate use of these data for the purpose of conducting public health surveillance,
in close collaboration with leadership and research analysts at the Centers for Disease
Control and Prevention, Brown University investigators propose to Investigate the
validity of infection data in the nursing home EMR by exploring the viability of using the
EMR data to identify two infectious conditions among nursing home residents. These
will be selected in consultation with CDC officials and could range from the occurrence
of SARS-CoV-2 and other pulmonary viruses to other common conditions like C-Difficile
with the goal of creating indicators of the incidence of each type of infection that
appears valid and reliably detected.
项目摘要
NIA IMPACT合作实验室COVID相关补充,资助长期
护理数据合作社[U 54 AG 063546 - 02 S6]建立了一个合作社,
构建养老院电子病历(EMR)集中存储库
来自三个不同EMR供应商的数据。许多养老院公司使用一个
这三家供应商中有三家已注册成为会员,授权其EMR供应商
将临床相关数据(包括标识符)传输到集中存储库
在美国卫生保健协会(AHCA)的赞助下运作
大多数美国疗养院的会员协会[https://www.ahcancal.org/Data-
/Pages/LTC-Data-Cooperative.aspx]。除了监管
所需的最小数据集信息,整合的EMR数据包括所有
流行和事件诊断、医嘱、给药记录、
条件记录,每日生命体征,事件报告,疫苗接种,行为跟踪,
认知和身体功能的日常变化,对于某些设施,实验室
和诊断测试结果。
为了方便使用这些数据进行公共卫生监测,
与疾病中心的领导层和研究分析师密切合作,
控制和预防,布朗大学的调查人员建议调查
有效性的感染数据在养老院电子病历探索的可行性,使用
EMR数据,以确定疗养院居民中的两种传染病。这些
将在与CDC官员协商后选择,
SARS-CoV-2和其他肺部病毒与其他常见疾病(如艰难梭菌)的关系
目的是建立每种感染发生率的指标,
看起来是有效的,并且可以被可靠地检测到。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUSAN L MITCHELL其他文献
SUSAN L MITCHELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUSAN L MITCHELL', 18)}}的其他基金
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10183561 - 财政年份:2019
- 资助金额:
$ 19.97万 - 项目类别:
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10005976 - 财政年份:2019
- 资助金额:
$ 19.97万 - 项目类别:
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10229425 - 财政年份:2019
- 资助金额:
$ 19.97万 - 项目类别:
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10358216 - 财政年份:2019
- 资助金额:
$ 19.97万 - 项目类别:
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10183547 - 财政年份:2019
- 资助金额:
$ 19.97万 - 项目类别:
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10285112 - 财政年份:2019
- 资助金额:
$ 19.97万 - 项目类别:
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10443662 - 财政年份:2019
- 资助金额:
$ 19.97万 - 项目类别:
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10308958 - 财政年份:2019
- 资助金额:
$ 19.97万 - 项目类别:
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10310637 - 财政年份:2019
- 资助金额:
$ 19.97万 - 项目类别:
NIA AD/ADRD Health Care Systems Research Collaboratory
NIA AD/ADRD 医疗保健系统研究合作实验室
- 批准号:
10673655 - 财政年份:2019
- 资助金额:
$ 19.97万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 19.97万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 19.97万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 19.97万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 19.97万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 19.97万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 19.97万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 19.97万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 19.97万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 19.97万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 19.97万 - 项目类别: